BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 27, 2012
View Archived Issues
Liposomal irinotecan shows benefit in metastatic colorectal cancer
Read More
Risk loci for multiple myeloma identified
Read More
Phase IIa trial assesses daclatasvir/asunaprevir in difficult-to-treat hepatitis C
Read More
BioLineRx signs license agreement with Genoscience
Read More
Cephalon scientists disclose synthesis, pharmacological and first clinical data on CEP-11981
Read More
Novel polypeptides prepared by Zealand Pharma
Read More
Novel phosphodiesterase 10A inhibitors synthesized in Japan
Read More
New phosphodiesterase 4 inhibitors presented by Leo Pharma
Read More
Abbott profiles pipeline progress of 2011
Read More
German team patents new agents with neurogenic and neurotrophic properties
Read More
Recruitment begins in phase Ib/II U3-1287 combination study
Read More
Vertex Pharmaceuticals patents new serine/threonine-protein kinase ATR inhibitors
Read More
Merck & Co. designs new protein kinase inhibitors
Read More
RPCI launches first-ever trial of dendritic vaccine plus rapamycin
Read More
Celgene announces merger agreement
Read More
EMA grants orphan drug status to Celator product
Read More
Biogen Idec and Elan evaluate Tysabri in secondary progressive MS
Read More
Auxilium Pharmaceuticals doses first patients in Xiaflex study
Read More
Studies detail beta-amyloid detection with florbetapir F 18 PET
Read More
Kancera subsidiary and Agios Pharmaceuticals launch alliance
Read More
Lpath suspends dosing in clinical studies of iSONEP
Read More
BioAlliance Pharma outlines major achievements of 2011 and prospects for 2012
Read More
Enrollment begins in Japan in phase III trials of orteronel
Read More